![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1364-9027
Source: International Journal of Pharmaceutical Medicine, Vol.21, Iss.1, 2007-01, pp. : 39-41
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 612, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Physicians in Greece should consider atorvastatin in CHD
Inpharma, Vol. 1, Iss. 1343, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Leo Pharma to withdraw drugs from Greece
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 605, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Physicians in Greece should consider atorvastatin in CHD
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 368, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Single-pill triple BP therapy good news in Greece
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 667, 2012-01 ,pp. :